Evidence map›Paper›PMID 38926493›Full record

ArticleThe Journal of antibiotics2024

Actinoplanes kirromycinicus sp. nov., isolated from soil.

Jiahao Zeng, Yohei Iizaka, Moriyuki Hamada, Aya Iwai, Riku Takeuchi, Atsushi Fukumoto, Tomohiko Tamura, Yojiro Anzai

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of antibiotics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiahao ZengFaculty of Pharmaceutical Science, Toho University, 2-2-1 Miyama, Funabashi, Chiba, 274-8510, Japan.
Yohei IizakaFaculty of Pharmaceutical Science, Toho University, 2-2-1 Miyama, Funabashi, Chiba, 274-8510, Japan. yohei.iizaka@phar.toho-u.ac.jp.ORCID 0000-0002-5951-4511
Moriyuki HamadaBiological Resource Center, National Institute of Technology and Evaluation (NBRC), 2-5-8 Kazusakamatari, Kisarazu, Chiba, 292-0818, Japan.ORCID 0000-0001-8239-6296
Aya IwaiFaculty of Pharmaceutical Science, Toho University, 2-2-1 Miyama, Funabashi, Chiba, 274-8510, Japan.
Riku TakeuchiFaculty of Pharmaceutical Science, Toho University, 2-2-1 Miyama, Funabashi, Chiba, 274-8510, Japan.
Atsushi FukumotoFaculty of Pharmaceutical Science, Toho University, 2-2-1 Miyama, Funabashi, Chiba, 274-8510, Japan.
Tomohiko TamuraBiological Resource Center, National Institute of Technology and Evaluation (NBRC), 2-5-8 Kazusakamatari, Kisarazu, Chiba, 292-0818, Japan.ORCID 0000-0003-2755-3273
Yojiro AnzaiFaculty of Pharmaceutical Science, Toho University, 2-2-1 Miyama, Funabashi, Chiba, 274-8510, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel actinomycete, designated as TPMA0078

Indexed as

PhylogenyRNA, Ribosomal, 16SSoil MicrobiologyBacterial Typing TechniquesCell WallDNA, BacterialFatty AcidsJapanMicromonosporaceaeNucleic Acid HybridizationSequence Analysis, DNADNA, BacterialFatty AcidsRNA, Ribosomal, 16S

Identifiers

PMID38926493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.